Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
Clinical trial NCT01023308 · COMPLETED
Trial details
- NCT number
- NCT01023308
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-21
- Primary completion
- 2015-07-30
- Enrollment
- 767
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.